Clinical Trials Directory

Trials / Unknown

UnknownNCT04559789

Reducing Dementia Risk With Digital Health Coaching

Digital Cognitive Multidomain Alzheimer's Risk Velocity Study (DC-MARVEL)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Neurotrack Technologies, Inc. · Industry
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Accepted

Summary

The Digital Cognitive Multi-domain Alzheimer's Risk Velocity (DC MARVEL) study is a 2-year randomized controlled trial on dementia prevention. The purpose of this study is to determine the effect of a digital cognitive health program on dementia risk, cognitive function, and general health outcomes in middle age to older adults compared to a control group that receives health education.

Detailed description

Alzheimer's Disease (AD) is expected to affect 131 million people worldwide by 2050, but as many as 40% of these cases may be prevented by targeting modifiable risk factors such as diet, physical activity, cognitive engagement, and smoking. Neurotrack Technologies, Inc. will test the efficacy of a digital multi-domain lifestyle intervention with health coaching for cognitive health designed to change behaviors associated with increased risk for AD. This digital intervention addresses the challenge of scaling effective multi-domain lifestyle interventions for cognitive health and has the potential to improve risk behaviors, thereby reducing and/or delaying cognitive decline in older adults at risk for AD.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindMate + Health CoachingThe MindMate app is a digital multi-domain lifestyle intervention designed to address modifiable risk factors for dementia. The app will be augmented with digital health coaching provided by Neurotrack.
OTHERHealth EducationHealth education materials delivered electronically

Timeline

Start date
2021-01-04
Primary completion
2024-01-30
Completion
2024-01-30
First posted
2020-09-23
Last updated
2021-08-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04559789. Inclusion in this directory is not an endorsement.